SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $957,327 | -17.4% | 20,360 | +221.5% | 0.13% | -15.7% |
| Q2 2019 | $1,159,000 | -39.3% | 6,332 | -68.2% | 0.16% | +6.0% |
| Q4 2018 | $1,908,000 | +271.2% | 19,922 | +447.0% | 0.15% | +150.0% |
| Q3 2018 | $514,000 | -35.7% | 3,642 | -28.6% | 0.06% | -40.0% |
| Q2 2018 | $799,000 | +0.6% | 5,102 | +3.5% | 0.10% | -3.8% |
| Q1 2018 | $794,000 | -25.0% | 4,929 | -23.4% | 0.10% | -25.7% |
| Q4 2017 | $1,059,000 | +149.2% | 6,431 | -5.8% | 0.14% | +141.4% |
| Q3 2017 | $425,000 | -83.1% | 6,826 | -78.4% | 0.06% | -83.9% |
| Q2 2017 | $2,521,000 | +14.9% | 31,660 | +2.5% | 0.36% | +4.9% |
| Q1 2017 | $2,194,000 | +268.1% | 30,873 | +164.6% | 0.34% | +251.0% |
| Q4 2016 | $596,000 | – | 11,669 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |